As a service provider, we utilise the Intellicyt iQue Screener PLUS platform - an integration of instrument, software, and reagents that enables rapid, high-content, multiplexed analysis of cells and beads in suspension. This cutting-edge technology allows for high-throughput flow cytometry, providing the ability to quickly analyze millions of cells in a single run across multiple parameters, with as little as 1 µL of sample. Ideal for drug discovery, immunology, and toxicity testing, the platform enables efficient, large-scale screening and delivers detailed cellular insights, helping our clients accelerate their research and development efforts.

Enhancing the productivity of iQue® HTS, the 21 CFR Part 11 Compliance-Enabling Module (especially when handling clinical samples) supports the maintenance of electronic records with integrated global event tracking, electronic signatures, and additional compliance features.